Astera Labs (NASDAQ:ALAB) Shares Gap Up – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALABGet Free Report)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $113.77, but opened at $119.54. Astera Labs shares last traded at $119.69, with a volume of 2,226,602 shares trading hands.

Wall Street Analyst Weigh In

ALAB has been the topic of several recent research reports. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Citigroup cut their price objective on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Raymond James Financial assumed coverage on Astera Labs in a report on Friday, November 21st. They set a “hold” rating for the company. Royal Bank Of Canada started coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Finally, Roth Mkm increased their price target on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $195.89.

Get Our Latest Stock Analysis on Astera Labs

Astera Labs Trading Up 6.8%

The company has a 50-day moving average of $154.84 and a 200-day moving average of $170.88. The company has a market capitalization of $20.68 billion, a price-to-earnings ratio of 99.61, a price-to-earnings-growth ratio of 2.16 and a beta of 1.74.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the prior year, the company posted $0.37 earnings per share. The company’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Transactions at Astera Labs

In other news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00. Following the completion of the transaction, the general counsel directly owned 128,084 shares in the company, valued at $15,046,027.48. This trade represents a 7.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jitendra Mohan sold 94,971 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief executive officer directly owned 1,452,739 shares of the company’s stock, valued at $179,863,615.59. This trade represents a 6.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 216,792 shares of company stock worth $26,777,569. Insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in shares of Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after purchasing an additional 84,365 shares in the last quarter. State Street Corp raised its stake in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Fred Alger Management LLC boosted its stake in Astera Labs by 25.5% during the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Finally, Morgan Stanley grew its holdings in shares of Astera Labs by 33.0% during the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after buying an additional 480,009 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.